Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.63 -0.02 (-0.26%)
As of: Sep 30, 2026 · 2:38 PM EDT

Maravai Lifesciences Holdings (MRVI) EBITDA Margin (2020 - 2026)

Updated

Maravai Lifesciences Holdings' EBITDA Margin came in at -6.43% for Q2 2026, up 105.65 percentage points from -112.08% a year earlier but down 20.42 percentage points from the prior quarter.

Analysis

Maravai Lifesciences Holdings (MRVI) EBITDA Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Maravai Lifesciences Holdings reported EBITDA Margin of -32.69%, up 89.46 percentage points year-over-year; for FY2025, it was -88.14%, down 15.92 percentage points from FY2024.

  • EBITDA Margin has declined in each of the last four years, with a five-year change of -139.47 percentage points (FY2020 to FY2025).
  • Going back by year, EBITDA Margin was -72.22% in FY2024 (-75.20 pp), 2.98% in FY2023 (-65.66 pp), 68.64% in FY2022 (-3.85 pp) and 72.49% in FY2021 (+21.17 pp).
  • The five-year range for quarterly EBITDA Margin is -222.64% (Q3 2024) to 78.99% (Q3 2021).
  • Year-over-year, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -17.22 percentage points.
  • The fastest year-over-year change in EBITDA Margin over five years came in Q3 2025 (a gain of 155.75 percentage points), and the weakest in Q3 2024 (a drop of 215.95 percentage points).
  • Business Quant data shows MRVI's EBITDA Margin at 14.00% (Q1 2026), -92.86% (Q4 2025) and -66.89% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 21.86%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 41.08%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.55%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 31.93%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.62%
10 Maravai Lifesciences Holdings 1.99 Bn 1.44 Bn 20.65 Mn -6.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.43%
Mar 31, 2026 14.00%
Dec 31, 2025 -92.86%
Sep 30, 2025 -66.89%
Jun 30, 2025 -112.08%
Mar 31, 2025 -77.78%
Dec 31, 2024 -44.71%
Sep 30, 2024 -222.64%
Jun 30, 2024 -1.46%
Mar 31, 2024 -11.23%
Dec 31, 2023 4.93%
Sep 30, 2023 -6.69%
Jun 30, 2023 -2.83%
Mar 31, 2023 14.40%
Dec 31, 2022 57.39%
Sep 30, 2022 65.36%
Jun 30, 2022 77.80%
Mar 31, 2022 71.53%
Dec 31, 2021 70.01%
Sep 30, 2021 78.99%
API Access

Maravai Lifesciences Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRVI&period=max&api_key=YOUR_API_KEY